German Biotech Stock News

XTRA:PCZ
XTRA:PCZBanks

Why ProCredit Holding (XTRA:PCZ) Cut Its 2025 ROE Guidance and What This Means for Its Risk Appetite

In October 2025, ProCredit Holding AG’s Management Board revised the group’s 2025 return on equity guidance down to 7-8% from about 10%, citing increased loss allowances for the upcoming year. This development highlights the firm’s more cautious view on loan performance, even as guidance for loan portfolio growth and capital strength remains steady. We'll now explore how this lowered profit expectation, and its link to higher projected loss allowances, may shift ProCredit Holding's...
XTRA:DWS
XTRA:DWSCapital Markets

DWS Group (XTRA:DWS) Margin Jump Challenges Cautious Forecasts Despite Revenue Decline Outlook

DWS Group GmbH KGaA (XTRA:DWS) just posted annual earnings growth of 35.3%, a sharp jump over its five-year trend of only 1% annual growth. Although net profit margins have climbed from 15.1% to 18.5%, revenue is forecast to decline by 5.9% per year over the next three years, and earnings growth of 6.9% per year is projected to trail the broader German market’s 16.6% average. With the company trading at €55.4 per share, well below a fair value estimate of €94.44, and no major risks on the...